This podcast highlights opportunities for managed care organizations to improve COPD management by aligning coverage policies with current clinical evidence and treatment guidelines. Experts discuss new therapies, including recently approved biologics and inhaled agents, and their roles in treating patients with frequent exacerbations or type 2 inflammation. The session also addresses implementation barriers such as limited spirometry access, inconsistent pulmonary rehab availability, and disparities in care. Strategies for payer engagement include expanding telehealth, integrating social determinants of health data, enhancing care coordination, and supporting multidisciplinary care models to reduce hospitalizations and improve outcomes in patients with moderate to severe COPD.
This activity is certified for CME/CNE/CPE credit. To participate and earn
credit, visit us at https://www.impactedu.net/type2-inflammation-copd-management-ce/.
Podden och tillhörande omslagsbild på den här sidan tillhör
IMPACT. Innehållet i podden är skapat av IMPACT och inte av,
eller tillsammans med, Poddtoppen.
